West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$318.02 USD
+0.10 (0.03%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $318.06 +0.04 (0.01%) 6:42 PM ET
4-Sell of 5 4
D Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO7/25/24 |
---|---|
Current Quarter | 1.78 |
EPS Last Quarter | 1.56 |
Last EPS Surprise | 20.93% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 7.76 |
Next Year | 9.16 |
EPS (TTM) | 7.66 |
P/E (F1) | 40.96 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 738.87M | 778.70M | 3.01B | 3.27B |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 745.20M | 782.90M | 3.02B | 3.30B |
Low Estimate | 730.30M | 775.01M | 3.00B | 3.25B |
Year ago Sales | 753.80M | 747.40M | 2.95B | 3.01B |
Year over Year Growth Est. | -1.98% | 4.19% | 2.01% | 8.75% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.78 | 2.13 | 7.76 | 9.16 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | 1.77 | 2.10 | 7.66 | 9.06 |
High Estimate | 1.94 | 2.19 | 8.13 | 9.48 |
Low Estimate | 1.68 | 2.06 | 7.64 | 8.88 |
Year ago EPS | 2.11 | 2.16 | 8.08 | 7.76 |
Year over Year Growth Est. | -15.64% | -1.39% | -3.96% | 18.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.78 | 2.13 | 7.76 | 9.16 |
7 Days Ago | 1.78 | 2.13 | 7.76 | 9.16 |
30 Days Ago | 1.78 | 2.13 | 7.76 | 9.16 |
60 Days Ago | 1.78 | 2.13 | 7.76 | 9.16 |
90 Days Ago | 2.00 | 2.13 | 7.62 | 9.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.78 | 2.13 | 7.64 | 8.99 |
Zacks Consensus Estimate | 1.78 | 2.13 | 7.76 | 9.16 |
Earnings ESP | 0.00% | 0.00% | -1.56% | -1.84% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.56 | 1.83 | 2.16 | 2.11 | NA |
Estimate | 1.29 | 1.78 | 1.86 | 1.95 | NA |
Difference | 0.27 | 0.05 | 0.30 | 0.16 | 0.20 |
Surprise | 20.93% | 2.81% | 16.13% | 8.21% | 12.02% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more